ストックスクリーナーアプリを入手
7.01
2.68%
0.07
前日終値:
$7.08
開ける：
$7.24
24時間の取引高:
7,208
Relative Volume:
0.13
時価総額：
$177.07M
収益：
$60,000
当期純損益:
$-54.55M
株価収益率:
-2.3824
EPS:
-2.9424
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-9.13%
1か月 パフォーマンス:
-27.95%
6か月 パフォーマンス:
-28.02%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$7.10
$7.735
1週間の範囲:
$7.08
$8.15
52週間の値動き範囲:
$3.20
$21.00
Neonc Technologies Holdings Inc Stock (NTHI) Company Profile
名前
Neonc Technologies Holdings Inc
セクター
電話
310 663 7831
住所
23975 PARK SORRENTO, CALABASAS
Compare NTHI vs VRTX, REGN, ALNY, ARGX, INSM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NTHI
Neonc Technologies Holdings Inc
|
7.225 | 173.51M | 60,000 | -54.55M | 0 | -2.9424 |
VRTX
Vertex Pharmaceuticals Inc
|
452.38 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
754.66 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
329.83 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
687.64 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
147.26 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Neonc Technologies Holdings Inc (NTHI) 最新ニュース
Resistance Check: Is NeOnc Technologies Holdings Inc affected by consumer sentiment2026 Gainers & Stock Timing and Entry Methods - baoquankhu1.vn
Dip Buying: What are analysts price targets for NeOnc Technologies Holdings Inc2026 Earnings Impact & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
New to The Street Signs NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) to 12-Part National Broadcast Series Including T.V. Network Features, Earned Media, Commercials, and Iconic Outdoor Billboards - The Herald-Mail
NeOnc Technologies Holdings, Inc. Signs Material Definitive Agreements for Securities Purchase and Warrants – SEC Filing Details - Minichart
NeOnc Announces New Private Placement to Support Liquidity - TipRanks
NeOnc Technologies Launches Third Equity Round: Up to 545,583 Shares at $7.20, $1M First Close - TradingView
Breakouts Watch: What is the implied volatility of NeOnc Technologies Holdings Inc2026 Spike Watch & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
NeOnc Technologies Holdings, Inc. announced that it expects to receive $3.928198 million in funding - marketscreener.com
Neonc Technologies (NTHI) to Release Earnings on Friday - Defense World
Swing Trade: Will NeOnc Technologies Holdings Inc benefit from government policyTrade Exit Report & Fast Gain Swing Trade Alerts - baoquankhu1.vn
NeOnc Technologies Appoints David Choi as Chief Accounting Officer to Strengthen Financial Leadership Amid Clinical Expansion - Minichart
Trade Recap: Does NeOnc Technologies Holdings Inc have declining or rising EPSQuarterly Portfolio Report & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn
NeOnc Technologies Appoints New Chief Accounting Officer - TipRanks
Neonc appoints David Choi as Chief Accounting Officer - TradingView
NeOnc Technologies appoints David Choi as chief accounting officer - Investing.com India
Neonc Technologies Stock Price Dips 0.1% - National Today
NeOnc Technologies appoints David Choi as chief accounting officer By Investing.com - Investing.com Australia
NeOnc Technologies Holdings, Inc. Appoints David Choi as Chief Accounting Officer - marketscreener.com
NeOnc Technologies Appoints David Choi as Chief Accounting Officer - GlobeNewswire
NTHINeOnc Technologies Holdings Inc Latest Stock News & Market Updates - Stock Titan
Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NTHI) - marketscreener.com
Neonc Technologies (NASDAQ:NTHI) Trading Down 0.1% – Should You Sell? - Defense World
NeOnc sets Phase 2 dose for brain cancer drug NEO212 - Investing.com Nigeria
Surprises Report: Is NeOnc Technologies Holdings Inc. stock oversold or undervaluedPortfolio Return Report & Scalable Portfolio Growth Methods - Naître et grandir
NeOnc Reports Phase 1 NEO212 Results, Sets Phase 2 Dose - TipRanks
NeOnc Technologies Reports RP2D of 610 mg for Oral NEO212 after Phase 1 Dose-Escalation - TradingView
Breakouts Watch: Is NeOnc Technologies Holdings Inc affected by consumer sentiment2025 Trading Volume Trends & Verified Stock Trade Ideas - baoquankhu1.vn
Published on: 2026-03-05 20:09:42 - baoquankhu1.vn
NeOnc Technologies settles dispute with Fox Infused for $737,920.77 payment - Investing.com Australia
NeOnc Technologies Settles Fox Infused Dispute With Payment - TipRanks
NeOnc Technologies Reports Phase 1 Dose-Escalation Results for Dosing and Toxicity and Determination of Recommended Phase 2 Dose for Oral NEO212; Management to Host KOL Conference Call Today at 9 a.m. ET - Bitget
Earnings Risk: Will NeOnc Technologies Holdings Inc benefit from government policy2025 Earnings Surprises & Weekly Top Stock Performers List - baoquankhu1.vn
NeOnc sets Phase 2 dose for brain cancer drug NEO212 By Investing.com - Investing.com Canada
NeOnc Technologies Holdings Reports Phase 1 Dose-Escalation Results and Determines Recommended Phase 2 Dose for Oral Neo212 - marketscreener.com
NeOnc Technologies Completes Late-February Private Equity Offerings - TipRanks
NeOnc to Present Initial NEO212 Phase 1 Data - TipRanks
NeOnc to present Phase 1 dose-escalation safety, PK data from NEO212-01 on March 4 - TradingView
NeOnc Technologies to present Phase 1 trial data on March 4 - Investing.com Nigeria
NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Dose-Escalation Results from Full Phase 1 NEO212-01 Readout for Dosing and Toxicity - Bitget
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
NTHI Technical Analysis & ETF Price Forecast - Intellectia AI
New to The Street to Broadcast Executive Leadership Interviews Tonight at 6:30 PM EST on Bloomberg Television Across the U.S., MENA and Latin America - Sacramento Bee
User - The Chronicle-Journal
What are analysts’ price targets for NeOnc Technologies Holdings Inc.Bear Alert & Verified Momentum Stock Alerts - mfd.ru
Why NeOnc Technologies Holdings Inc. stock remains resilientPortfolio Growth Summary & Technical Analysis for Trade Confirmation - mfd.ru
New to The Street to Broadcast Show #726 on Bloomberg at 6:30 PM EST Featuring Vivos Therapeutics (NASDAQ:VVOS), Aeries Technology (NASDAQ:AERT), Virtuix Holdings (NASDAQ:VTIX), and Stardust Power (NASDAQ:SDST) - The Desert Sun
Will NeOnc Technologies Holdings Inc. stock outperform value stocksEarnings Growth Report & Weekly Setup with ROI Potential - mfd.ru
Neonc Technologies Holdings Inc (NTHI) 財務データ
収益
当期純利益
現金流量
EPS
Neonc Technologies Holdings Inc (NTHI) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Heshmatpour Amir F | President |
Nov 24 '25 |
Buy |
6.51 |
6,000 |
39,060 |
2,992,000 |
| Neman-Ebrahim Yousha | Chief Clinical Officer |
Nov 20 '25 |
Buy |
6.69 |
1,100 |
7,359 |
134,260 |
| Heshmatpour Amir F | President |
May 23 '25 |
Buy |
7.39 |
2,000 |
14,785 |
1,762,000 |
| CHEN THOMAS C | CEO |
May 21 '25 |
Buy |
7.25 |
2,759 |
20,002 |
548,959 |
| CHEN THOMAS C | CEO |
May 22 '25 |
Buy |
7.38 |
2,709 |
20,000 |
551,668 |
| GARNETT KEITHLY | CFO |
May 22 '25 |
Buy |
7.29 |
675 |
4,921 |
240,900 |
| GARNETT KEITHLY | CFO |
May 19 '25 |
Buy |
7.23 |
135 |
976 |
240,225 |
| Delshad Jim | Director |
May 12 '25 |
Buy |
7.22 |
5,000 |
36,110 |
55,310 |
| Delshad Jim | Director |
Apr 17 '25 |
Buy |
6.92 |
50 |
346 |
50,310 |
| CHEN THOMAS C | CEO |
May 12 '25 |
Buy |
7.00 |
400 |
2,800 |
546,200 |
0.99%
3.03%
大文字化:
|
ボリューム (24 時間):